The Continuous Positive Airway Pressure (CPAP) Devices Market Size was valued at USD 2.57 Billion in 2023. The global CPAP devices industry is projected to grow from USD 2.70 Billion in 2024 to USD 4.78 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.45% during the forecast period (2024 - 2032).
CPAP devices are commonly used to treat obstructive sleep apnea syndrome. The device operates by releasing air into the nose and throat. The blow induces a positive pressure to hold the upper airway open when the patient is asleep. This helps to treat snoring or breathing problems. The ever-increasing technological advancements deployed in the CPAP devices are also expected to fuel market growth.
The CPAP devices market is accelerated by the rising number of patients with sleep apnea, obesity, or other respiratory disorders. Reports suggest that a large portion of the global population is obese. Hence, this has led to a rise in respiratory issues among people of all age groups. The fast-growing number of people with obesity helps demand the continuous positive airway pressure devices market size.
FDA 510(k) Clearance for Vivos Therapeutics’ CARE (Complete Airway Repositioning and/or Expansion) oral devices designed for adults with severe obstructive sleep apnea (OSA) was awarded in November 2023. Included in this clearance are the firm’s top DNA, mRNA and mmRNA oral appliances.Â
In Korea, Samsung Electronics announced in October 2023 that on its Health Monitor app it has a new sleep apnea feature authorized by the Ministry of Food and Drug Safety (MFDS). In Korea, the Galaxy Watch series will have this element as early as 2024.Â
ResMed and Bittium Biosignals Ltd. –a subsidiary of Bittium Corporation– agreed in October 2023 that ResMed would distribute Bittium Respiro, an advanced Home Sleep Apnea Test and Analysis Solution. The whole package includes the Bittium Respiro measuring device, accessories as well as the Bittium Respiro Analyst software analysis tool and service platform.Â
United States-based medical equipment company ResMed introduced AirSense 11 to the market in August 2021. The PAP (positive airway pressure) device aims to assist individuals with sleep apnea.
Philips has partnered with Cognizant medical providers since July 2021 to create more end-to-end solutions. The aim is to have integrated digital health solutions from Philips & Cognizant that enhance patient care across healthcare providers and accelerate clinical trials among life sciences companies.
The current agreement between Elekta and Philips was signed by these two companies in June 2012 to deepen their existing strategic partnership focused on advancing comprehensive, personalized cancer care through precision oncology solutions. This new stage of collaboration builds on the earlier successful efforts of two firms in the growing field of magnetic resonance-guided adaptive radiation therapy.
Covid-19 Analysis
After the impact of Covid-19 across the globe, many large-scale businesses and industries suffered, except healthcare and life support products. The lockdown and physical distancing protocols also affected many small and big business institutions alike. However, the continuous positive airway pressure devices market saw significant growth after the pandemic.
This is because the rise in Covid-19 cases also led to a demand for respiratory aid devices to help patients breathe easier. There is also a shortage of ventilators around the world, which made hospitals switch to alternative breathing aids such as CPAP devices. Hence, these factors are expected to fuel the market growth even during the pandemic.
A few factors may drive the continuous positive airway pressure devices market growth. The rising cases of obesity, sleep apnea, and Covid-19 around the world have led to a demand for breathing aid devices. However, this may also lead to high healthcare expenditure. Hence, CPAP devices serve as the ideal alternative to conventional breathing aids. These factors are expected to fuel the global market growth.
The major companies that account for the largest CPAP devices market share adopt various market trends such as new product launches in the field. The advancements in technology and research are adding to its growth. Moreover, most companies are also adopting R&D market trends. Hence, these factors serve as opportunities for global CPAP devices market growth.
There are a few factors that may inhibit the growth of the continuous positive airway pressure devices industry. One of the most important of them is the high cost of the CPAP devices. They are often not affordable for everyone. Moreover, the use of these devices also has adverse effects on the patients. Hence, these factors may hinder the CPAP devices market growth in the long run.
Most patients who use the CPAP devices have reported that devices feel uncomfortable and do not seem fit for everyday use. They also seem to have adverse side effects on the patients who use the device. Hence, the CPAP devices manufacturer companies often find it challenging to cater to the expectations of the consumers. This may slow down the continuous positive airway pressure devices market growth in the forecast period.
The continuous positive airway pressure devices market outlook is expected to be prosperous. This is because of the growing number of sleep apnea cases among the global population. The CPAP devices help increase the air pressure in the throat to prevent the airway from collapsing when breathing. These devices are suitable for everyday use at home while asleep.
The CPAP devices are also available in two types of automation technology – manual and automatic. The automatic devices are run by automatically controlling the air pressure in the airway. The automatic CPAP device market is witnessed the fastest growth rate over the forecast years. Post the pandemic, people affected with Covid-19 often suffer from breathing issues. Hence, continuous positive airway pressure devices can be used to aid patients in breathing.
The global continuous positive airway pressure devices market is classified into many segments such as by product type, automation, features, and end-user. Listed below are the CPAP devices market segments:
CPAP mask
CPAP motors
CPAP hoses
Others
Automatic
Manual
Heated tubing
Humidifier
Portability
Others
Home care
Hospitals
Private clinics
Others
The regional analysis of the global continuous positive airway pressure devices market includes the Asia Pacific region, the Americas, Europe, and the rest of the world. Among them, North America is anticipated to dominate the CPAP devices market during the forecast period. This is because of the increasing number of unhealthy diets, obesity, and physical inactivity cases in the region.
Moreover, the region has a large share of people with chronic bronchitis. Also, most of the leading CPAP device manufacturing companies belong to this region. It is estimated to be followed by Europe, with the second-largest share in the global continuous positive airway pressure devices industry.
However, the Asia Pacific region is anticipated to witness the fastest market growth rate over the forecast period. This is because the Asia Pacific comprises a large share of people with unhealthy diet habits and lifestyles. Moreover, the region is witnessing a growth in healthcare technology development.
The CPAP devices market is dominated by a few companies that play a vital role in the growth of the market. These CPAP devices manufacturing companies are called the key companies. They contribute to the largest share of the market profit by adopting many continuous positive airway pressure devices market trends. These companies offer highly advanced and innovative devices that induce CPAP.
Below are the key companies that offer CPAP devices in the global market, with the location of their headquarters:
Armstrong Medical Inc. (US)
Beijing Dehaier Medical Technology Co. Ltd. (China)
Medtronic (US)
Cardinal Health (US)
Invacare Corporation (US)
Koninklijke Philips N.V. (Netherlands)
Apex Medical Corp. (Taiwan)
ResMed (US)
3B Medical Inc. (US)
Fisher & Phillips LLP (US)
DeVilbiss Healthcare LLC (US)
Smiths Medical (US)
ResMed has shifted its focus to maximize the production of respiratory support or CPAP devices to help resolve the respiratory complications caused due to Covid-19.
This report delivers all the information about the growth of the global continuous positive airway pressure devices market in the forecast period. It also contains different sections of the market analysis to help obtain detailed information such as opportunities, challenges, drivers, Covid-19 analysis, regional analysis, competitive landscape, and others. Moreover, all the information is collected from verified primary and secondary sources to provide the expected continuous positive airway pressure devices market analysis for the forecast period.
Geographically
Europe
Asia-Pacific
The Americas
Middle East & Africa
Rest of the world
| Attribute/Metric | Details |
| Market Size 2023 | 2.57 (USD Billion) |
| Market Size 2024 | 2.7 (USD Billion) |
| Market Size 2032 | 4.78 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 7.45 % (2024 - 2032) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2023 |
| Market Forecast Period | 2024 - 2032 |
| Historical Data | 2019 - 2023 |
| Â Â Geographies Covered | Â Â North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Â Â Key Vendors | Â Â Medtronic (U.S.), Koninklijke Philips N.V. (the Netherlands), 3B Medical, Inc. (U.S.), Armstrong Medical Inc. (U.S.), ResMed (U.S.), Smiths Medical (U.S.), Apex Medical Corp. (Taiwan), Fisher & Phillips LLP (U.S.), Cardinal Health (U.S.) Beijing Dehaier Medical Technology Co., Ltd. (China), DeVilbiss Healthcare LLC (US), and Invacare Corporation (US). |
| Â Â Key Market Opportunities | Â Â New product launches and R&D Amongst major key Players |
|   Key Market Drivers | · Rising Healthcare Expenditure · Growing prevalence of sleep |
Continuous Positive Airway Pressure Devices Market Highlights:
Frequently Asked Questions (FAQ) :
CPAP devices are widely used to treat sleep apnea and exert a positive pressure inside the patient’s respiratory tract in order to prevent snoring and other breathing-related problems.
The Continuous Positive Airway Pressure (CPAP) Devices Market is expected to exhibit a strong 7.45% CAGR over the forecast period from 2024 to 2032.
Growing prevalence of sleep apnea is the major driver for the Continuous Positive Airway Pressure (CPAP) Devices Market.
The Americas hold the largest share in the Global Continuous Positive Airway Pressure (CPAP) Devices Market.
Leading players in the CPAP devices market include Koninklijke Philips, Medtronic, and 3B Medical, among others.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
